Unión Europea - español - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Unión Europea - español - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tipo 2 - drogas usadas en diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).

Unión Europea - español - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Unión Europea - español - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

3m peru s.a. - clorhidrato de lidocaina; clorhidrato de epinefrina; - solucion inyectable - por carpula 1.00 carp - lidocaÍna, combinaciones

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

fresenius kabi espaÑa, s.a.u. - lidocaina hidrocloruro - soluciÓn inyectable - 10 mg/ml inyectable 10 ml - lidocaina hidrocloruro 10 mg - lidocaína

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

fresenius kabi espaÑa, s.a.u. - lidocaina hidrocloruro - soluciÓn inyectable - 20 mg/ml inyectable 10 ml - lidocaina hidrocloruro 20 mg - lidocaína

Argentina - español - SANI (Asociación de Cooperativas Argentinas)

laboratorio veterinario proagro s.a. - oxitetraciclina clorhidrato; bencidamina clorhidrato; lidocaína clorhidrato; agentes de formulación c.s.p. - oxitetraciclina clorhidrato 6,4 g; bencidamina clorhidrato 2,00 g; lidocaína clorhidrato 2,00 g; agentes de formulación c.s.p. 100 ml - antibiótico y antiinflamatorio en solución inyectable lista para usar. la asociación en un mismo fármaco de un antibiótico de amplio espectro y un antiinflamatorio de síntesis con acción antipirética y analgésica constituye una terapéutica eficaz y actualizada sobre todo proceso que infiera inflamación infección. - aves; bovinos; caninos; conejos; equinos; felinos; ovinos; porcinos

Argentina - español - SANI (Asociación de Cooperativas Argentinas)

generar laboratorio veterinario - oxitetraciclina clorhidrato; loperamida clorhidrato; lidocaina clorhidrato; excipientes c.s.p. - oxitetraciclina clorhidrato 10 g.; loperamida clorhidrato 0,04 g.; lidocaina clorhidrato 1 g.; excipientes c.s.p. 100 ml. - bovinos; caninos; equinos; ovinos; porcinos

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios davur s.l. - hidroxocobalamina acetato, piridoxina hidrocloruro, lidocaina hidrocloruro, tiamina hidrocloruro, dexametasona fosfato sodio - soluciÓn inyectable - n/a (más de 4 pa) - n/a (más de 4 pa) n/a (más de 4 pa) - corticosteroides y vitaminas, combinaciones con